Align Financial’s Labcorp LH Stock Holding History

Align Financial’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$308	Buy	+1	New	+$310	﹤0.01%	572

Other funds holding LH

Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Davidson Investment Advisors Great Falls, Montana $2.39B AUM 16.28% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

McRae Capital Management Morristown, New Jersey $540M AUM 15.41% 1-Year Est. Return

Equitable Trust Nashville, Tennessee $2.38B AUM 22.38% 1-Year Est. Return

American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $861M AUM 27.19% 1-Year Est. Return

Weybosset Research & Management Province, Rhode Island $347M AUM 23.23% 1-Year Est. Return

Align Financial's LH Position: Q3 2026 in Review

Align Financial opened a new position in Labcorp (LH) in Q3 2026: 1 share worth $308. The stake represents ﹤0.01% of the portfolio and ranks #572 among its holdings.

203 funds tracked by Wall St. Rank hold LH as of Q3 2026.

Align Financial held 1 share of Labcorp worth $308 as of Q3 2026.
Labcorp was a new Align Financial position in Q3 2026.
Labcorp made up ﹤0.01% of Align Financial's portfolio in Q3 2026, its #572 holding.
203 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Align Financial's 13F filing for Q3 2026, filed 16 Oct 2026.